• Non ci sono risultati.

13 Sick Sinus Syndrome

N/A
N/A
Protected

Academic year: 2022

Condividi "13 Sick Sinus Syndrome"

Copied!
10
0
0

Testo completo

(1)

Sick Sinus Syndrome

William A. Scott

Sick sinus syndrome is a clinical entity that has been associated with a variety of arrhyth- mias. One of the earliest descriptions by Lown stated: “a defect in the elaboration or con- duction of sinus impulses characterized by chaotic atrial activity, changing P-wave con- tour, bradycardia, interspersed with multiple and recurrent ectopic beats with runs of atrial and nodal tachycardia.” While there are nu- merous etiologies described in the literature, sinus node dysfunction in pediatric patients most often occurs secondary to injury to the node itself, its arterial supply and/or its auto- nomic innervation in the course of cardiac sur- gical interventions. This injury is usually not limited to the sinoatrial node, and abnormali- ties in atrial automaticity and conduction are included in the sick sinus syndrome (Table 1).

There is evidence that the abnormal variation in heart rate has a destabilizing effect on the atrial tissue, contributing to the progression of the disease. While not specifically part of si- nus node disease, these coexisting atrial and, to a lesser degree, atrioventricular conduc- tion disturbances, support the concept that the pathology affecting the sinus node is diffuse.

Conditions associated with a high preva- lence of sick sinus syndrome include atrial repair of d-transposition of the great arter- ies, complete repair for anomalous pulmonary venous drainage and atrial septal defect, and

single ventricle palliation with the Fontan op- eration, although almost any open heart repair may result in sinus node impairment. Con- genital sinus node abnormalities are less fre- quent. Sinus node malformation is associated with left atrial isomerism and sinus node dys- function may coexist with congenital com- plete heart block. Familial clustering has been reported in the absence of structural heart dis- ease. Extrinsic causes of sinus node dysfunc- tion include autonomic imbalance and med- ications. Heavily conditioned athletes have bradycardia and sinus pauses of greater than 2 seconds due to prominent vagal influence.

Recently, sleep apnea has been related to si- nus node dysfunction. Many antiarrhythmia medications can further impair the sinus node function, particularly for patients with pre- existing abnormalities.

ECG CHARACTERISTICS

The ECG characteristics of sick sinus syndrome are variable and can change within a single patient. Not all patients will manifest all of the electrocardiographic findings noted be- low. Potential sources of electrocardiographic data include: standard 12–15 lead electrocar- diograms, Holter monitoring, event recorders, and rhythm strips from physiologic monitors.

153

(2)

154 SICK SINUS SYNDROME

TABLE 1. Sick Sinus Syndrome

Electrocardiographic Manifestations of Sick Sinus Syndrome

Sinus Bradycardia Extreme Sinus Arrhythmia Tachycardia-Bradycardia Syndrome Sinoatrial Exit Block

Sinus Pause/Sinus Arrest Sinoatrial Reentrant Tachycardia

Electrocardiographic Findings Associated with Sick Sinus Syndrome

Intra-atrial Reentrant Tachycardia (IART) Atrial Fibrillation

AV Nodal Dysfunction

Clear documentation is not always present in short-term recordings. Multiple leads should be recorded to detail P-wave morphology.

Long-term recordings with Holter pro- vide an overview of overall heart rate variation (Figure 1) and the prevalence of abnormally slow and fast rhythms. Ideally three orthog- onal leads are recorded to optimize P-wave recognition (i.e., Lead I, Lead II or III, and a precordial lead). Event recorders, particularly those with continuous storage capabilities, allow for correlation of symptoms to electro- cardiographic changes. Newer devices have programmable parameters for automated recording of tachycardia and bradycardia episodes. An implantable device is available for special circumstances that preclude wear- ing an external monitor.

Exercise testing is useful to assess the chronotropic response. All children and ado- lescents should be able to attain a heart rate of

FIGURE 1. Full disclosure printout from a Holter monitor. Individual complexes are too small for detailed evaluation, but abnormal pattern of heart rate variation is apparent.

180 bpm. Patients with sinus node dysfunc- tion also may have exaggerated slowing of heart rate or pauses in the recovery period.

Sinus Bradycardia

Bradycardia is the most common feature of sinus node dysfunction. Bradycardia may be sustained or paroxysmal. Escape rhythms (Figure 2) arise from the atrium, atrioventricu- lar (AV) node and ventricles, but these tissues are often dysfunctional and the escape rates are frequently lower than expected for age.

Healthy children may have brief periods of sinus bradycardia with atrial or junctional es- cape rhythm in the absence of any sinus node pathology. The normal heart rate is age de- pendent. The lowest values observed during Holter recording are less than those from ECG recording.

Recording artifacts and other rhythm abnormalities should be excluded. An abnor- mally low heart rate may be due to second- or third-degree AV block, as well as atrial and junctional extrasystoles. A sudden loss of sig- nal may appear similar to a sinus pause. There are often clues to this type of artifact includ- ing resumption of recording with a T-wave or a different time of drop out on another channel (Figure 3). Older Holter recorders using a tape drive mechanism can suddenly speed or slow, mimicking bradycardia or tachycardia.

With this type of artifact, all components of

the recording are expanded or compressed

(Figure 4).

(3)

FIGURE 2. Sinus bradycardia with alternating atrial and junctional escape rhythms in a patient 15 years after Mustard repair of d-transposition of the great arteries.

Extreme Sinus Arrhythmia

Sinus arrhythmia is a normal pattern of heart rate acceleration and decelera- tion present in most children. A signif- icant component of this variation is due

FIGURE 3. Simultaneous lead I (upper panel) and lead III (lower panel) from Holter recording. Apparent sinus pause is actually due to artifact. Signal loss is not simultaneous on both channels and lead I resumes rhythm with a T-wave, which is not possible.

to respiratory influences on the autonomic

nervous system. Abnormal or extreme si-

nus arrhythmia is defined as greater than

100% variation in PP intervals. Sinus node

exit block may also cause variation of this

magnitude.

(4)

156 SICK SINUS SYNDROME

FIGURE 4. Simultaneous lead V1 (upper) and V5 (lower) from Holter recording. Apparent bradycardia and tachy- cardia due to artifact from changing tape speed. Note that all components of the rhythm (P-wave, QRS complex, and T-wave) are compressed with tachycardia.

Tachycardia–Bradycardia

The tachycardia–bradycardia syndrome is diagnosed in the presence of recurrent prolonged pauses or sustained bradycardia following paroxysms of tachycardia. The tachycardia causes exaggerated overdrive suppression of already impaired automaticity, worsening the bradycardia (Figure 5).

Sinoatrial Exit Block

Sinoatrial exit block is failure of an im- pulse generated in the sinus node to propagate normally to the atrium. The degree of block is classified just as for the AV node. A di- rect recording of the sinus node electrogram is necessary to diagnose first degree sinoa- trial block. The pattern of PP intervals prior to a pause can be used to infer second-degree block. Mobitz I sinoatrial block (Figure 6) is

FIGURE 5. Tachycardia–bradycardia with junctional escape in a 2-year-old.

manifest by a gradual shortening of PP in- tervals followed by a pause of less than two times the resting cycle length. Mobitz II is pre- sumed to be the mechanism when a sudden pause of two times the resting cycle length is encountered (Figure 7). Both of these are difficult to recognize in the presence of sinus arrhythmia and both patterns may be due to abnormal impulse formation in the sinus node.

Neither of these conduction abnormalities can be absolutely proven without direct recording of the sinus node electrogram. Complete or third-degree sinoatrial block is indistinguish- able from sinus node arrest on the surface electrocardiogram.

Sinus Pauses and Sinus Arrest

Prolonged pauses are often present due to

either sinoatrial node exit block or sinus arrest

(Figure 8). Sinus pauses of less than 2 seconds

(5)

FIGURE 6. Lead I recording suggestive of Mobitz I type sinoatrial exit block. There is a gradual shortening of PP intervals, with a consistent P-wave morphology, followed by a pause of less than two times the resting cycle length.

Validation of this phenomenon requires invasive recording of the sinus node electrogram.

FIGURE 7. Simultaneous lead I and II recording suggestive of Mobitz II type sinoatrial exit block. There is a pause with a PP interval that is twice the resting cycle length. Validation of this phenomenon requires invasive recording of the sinus node electrogram.

are normal in young children and adolescents.

A non-sinus rhythm at a rate lower than ex- pected for sinus rhythm is referred to as an escape rhythm and is suggestive of sinus node arrest.

Sinoatrial Node Reentrant Tachycardia

Sinoatrial reentrant tachycardia is uncommon. It results from abnormal con- duction within the sinus node or immediate perinodal tissue. The P-waves are identical to those seen with sinus rhythm, but associated

FIGURE 8. Sinus arrest during a breath-holding spell. This represents transient sinus node dysfunction due to a sudden increase in parasympathetic activity.

with a paroxysmal increase and decrease in rate. This rhythm cannot be distinguished from a focal atrial tachycardia in close proximity to the sinoatrial node.

Atrial Flutter/Fibrillation

Typical atrial flutter is uncommon with sinus node dysfunction. More commonly atrial muscle reentry or intra-atrial reentrant tachycardia (IART) is observed (Figure 9).

This arrhythmia most frequently occurs fol-

lowing surgical interventions for congenital

(6)

158 SICK SINUS SYNDROME

FIGURE 9. Lead I (upper trace) and esophageal electrogram (lower trace) demonstrating intra-atrial reentrant tachy- cardia with 2:1 conduction. The arrhythmia is not apparent from surface ECG but esophageal recording shows atrial rate twice that of the ventricular rate.

heart disease. The rate is slower than that usu- ally ascribed to typical atrial flutter, usually around 180 to 300 bpm. There is an isoelec- tric interval between atrial activations, and the typical sawtooth pattern is not present, which confounds recognition of this rhythm. Unlike typical atrial flutter, 1:1 conduction to the ven- tricles is frequent. Most commonly 2:1 con- duction is observed, but again at a rate slower than typical for atrial flutter. Variable conduc- tion ratios may be misinterpreted as extrasys- toles. Atrial fibrillation is a late finding with disease progression.

ELECTROPHYSIOLOGIC FEATURES

Electrophysiologic studies have con- tributed greatly to the overall understanding of sinus node physiology. Typically these studies are conducted invasively with the placement of catheters through the vascular system for endocardial stimulation and recording. Lim- ited studies to assess sinus node function may also be performed with temporary epicar- dial or transvenous pacing wires (Figure 10),

esophageal pacing, and with a previously im- planted permanent pacemaker.

Presently, clinical history and non- invasive diagnostic studies primarily guide di- agnosis and management. Electrophysiologic study is not routinely performed solely for the diagnosis of sick sinus syndrome because it is invasive, has relatively low sensitivity and specificity, and noninvasive studies provide adequate information for management. Inva- sive electrophysiologic studies of sinus node function may be performed as an adjunct to hemodynamic study prior to surgical inter- vention or in association with interventional procedures such as radiofrequency ablation.

The primary measures of sinus node function are the sinoatrial conduction time and the corrected sinus node recovery time.

However, atrial refractoriness and intra-atrial conduction times are also prolonged with surgically-induced sick sinus syndrome.

Prolonged Sinoatrial Conduction Time

Sinoatrial conduction time is usually

measured by an indirect method (Chapter 3),

(7)

FIGURE 10. Recording of lead I (upper trace), atrial temporary pacing wire (middle trace), and ventricular pacing wire (lower trace). Patient has low amplitude atrial activity with first-degree AV block making rhythm determination difficult. Atrial wire electrogram consistent with sinus arrest or sustained sinoatrial exit block.

Strauss or Narula, which yields a total sinoa- trial conduction time (TSACT). The TSACT reflects conduction into and out of the sinus node. These conduction times are not equal;

therefore, it is more accurate to report a total sinoatrial conduction time rather than divide the TSACT by 2 and assume that the con- duction velocity in both directions is equiva- lent. Normal values for pediatric patients are

<200 msec. With the Strauss method, absence of a zone of reset suggests sinoatrial node en- trance block, which is abnormal as well. Sinus arrhythmia invalidates this measurement.

Directly recorded conduction times from the sinus node electrogram reflect only con- duction out of the sinus node and are usually shorter than the TSACT. As an independent measure of sinus node function, TSACT is relatively insensitive. Atropine has variable effects on TSACT in sinus node dysfunction.

In many patients the measurement normal- izes. Further prolongation of the TSACT is thought to be the result of depressed auto- maticity following enhanced conduction into the sinus node.

Prolonged Sinus Node Recovery Time The maximum corrected sinus node re- covery time (MCSNRT) (Chapter 3) is a measure of recovery of automaticity. Normal

values for MCSNRT are <250−270 msec for children, <445 msec for adolescents, and

<525 msec for adults. When expressed as a ratio, MCSNRT should be less than 150% of the sinus cycle length. At high rates, shorten- ing of the return cycle may occur due to reflex responses to hypotension, sinus node entrance block, or local release of catecholamines.

Abnormal results (Figure 11) may be sec- ondary to excess vagal tone and normalize following autonomic blockade whereas pa- tients with true dysfunction show no improve- ment following autonomic blockade. The specificity of this test may be enhanced by co- administration of disopyramide or autonomic blockade, but this has not been conclusively demonstrated in children. Other findings sug- gestive of sinus node dysfunction include sec- ondary pauses, and a prolonged total recovery time, defined as greater than 5–6 beats to re- turn to the resting cycle length. If MSCNRT occurs at long pacing cycle length, this sup- ports the diagnosis of sinus node disease.

TREATMENT

Prospective, randomized clinical trials

are not available to guide management in pe-

diatric patients. The presence of sick sinus

syndrome does not mandate therapy. Most

(8)

160 SICK SINUS SYNDROME

I

aVF

V1

V6 T

C S

500 msec

S1

9:50:39 AM 9:50:40 AM 9:50:41 AM 9:50:42 AM 9:50:43 AM

S1 S1 S1

854 msec

Junctional Escape hRA

HIS d

Stim 1 C

FIGURE 11. Abnormal response to overdrive pacing. The patient had a sinus cycle length of 550 msec. The sinus node should recover inn <275 msec. Here the recovery is prolonged (304 msec) and a junctional focus emerges before the sinus node. The junctional rhythm persists for 10 beats following termination of pacing.

patients with mild to moderate sinus node dys- function are asymptomatic and there is not a significant risk for sudden death in the asymp- tomatic individual.

Acute symptomatic bradycardia may be treated with atropine, isoproterenol, or tran- scutaneous pacing. Temporary transvenous or transesophageal pacing can be established un- til a permanent pacing system can be im- planted.

There is little role for drug therapy for the bradycardia associated with chronic sinus node dysfunction. Symptomatic bradycardia is treated with permanent pacing. Symp- tomatic bradycardia due to sinus node dys- function is a clear indication (Class I) for pace- maker placement. Asymptomatic episodes of heart rates under 40 bpm or pauses >3 sec- onds in the child are less clear indications for intervention (Class IIa), and in the ado- lescent (Class IIb). Consideration should be given to the patient’s size, cardiac anatomy, and AV nodal function, as well as the presence of any tachyarrhythmias. Atrial pacing has

significant advantages over ventricular pac- ing for the treatment of sick sinus syndrome;

therefore most patients receive atrial pace-

makers. A rate–response algorithm is pro-

grammed for those who appear to have sig-

nificant chronotropic incompetence. The rate

response can be optimized with exercise test-

ing and ambulatory Holter monitoring. Pa-

tients with any degree of AV nodal dysfunc-

tion, or for those where there is concern about

the reliability of atrial pacing, receive dual-

chamber pacemakers. Initially the AV delay

may be programmed to allow for native AV

conduction to occur. Later progression of AV

node dysfunction can be accommodated with

adjustment of the AV interval. Patients who

have had Mustard/Senning and Fontan palli-

ations for their congenital heart disease of-

ten have scarred atria complicating epicar-

dial lead placement. Transvenous placement,

while technically feasible, can significantly

increase the risk of thrombosis in the Fontan

baffle. Achieving and maintaining adequate

sensing and stimulation thresholds may be

(9)

FIGURE 12. Intra-atrial reentrant tachycardia following Fontan repair. The patient has a dual-chamber pacemaker and atrial sensed events (AS) show 2:1 conduction. In the lower panel, sinus rhythm is restored following overdrive stimulation through the pacemaker.

very challenging and rate support with ven- tricular pacing alone may have to be accepted.

Coexisting tachycardias complicate dual-chamber pacing. Rapid atrial rates that are tracked by the pacemaker may result in hemodynamic compromise from the high rate. Reducing the programmed upper rate limit is one method to avoid inappropriate tracking of tachycardia. Another is mode switching where the pacemaker automatically reverts to ventricular pacing only if the atrial rate exceeds a programmed threshold.

Symptomatic tachycardia is initially managed with pharmacologic therapy. De- tailed discussions of the management of IART and atrial tachycardia are found in chapters 4–10 of this text. The choice of medication must include consideration of the underlying heart disease, cardiac function, and the state of the remainder of the conduction system.

Digoxin may not significantly worsen brady- cardia in all patients and may help to decrease AV conduction of rapid tachycardias. Beta- blocking agents, sotalol, and amiodarone may all inhibit sinus or escape pacemaker auto- maticity such that permanent pacing is needed

to for rate support. Pharmacologic therapy should be initiated with continuous monitor- ing in the hospital. Catheter ablation has had suboptimal results; many patients require sur- gical revision concomitant with cryo or radio frequency ablation of arrhythmia substrates.

Select patients with infrequent arrhythmias that are reproducibly terminated by overdrive pacing (Figure 12) may be candidates for an- titachycardia pacemakers.

PROGNOSIS

Sick sinus syndrome is a progressive dis-

ease and deterioration of sinus node func-

tion continues into adulthood for survivors

of surgery for congenital heart disease. More

than 50% of patients with d-transposition who

have undergone venous repair develop some

degree of sinus node dysfunction, and up

to 20% will require pacing for sinus node

dysfunction during long-term follow-up. A

similar pattern has been observed for the

Fontan operation, but recent modifications

to the procedure may substantially decrease

(10)

162 SICK SINUS SYNDROME

the prevalence of sick sinus syndrome. Atrial pacing may slow the progression to atrial fib- rillation. Sudden death related to bradycardia or prolonged pauses are rare. The develop- ment of AV nodal dysfunction is also progres- sive, but relatively slow in both adult and pedi- atric studies. Over time the tachyarrhythmias are increasingly difficult to control and may require additional medical, catheter, or sur- gical interventions. Tachyarrhythmias have been noted as a risk factor for sudden death following surgery for congenital heart dis- ease.

SUGGESTED READING

1. Cohen MI, Rhodes LA. Sinus node dysfunction and atrial tachycardia after the Fontan procedure: The scope of the problem. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 1998;1:41–52.

2. Crawford MH, Bernstein SJ, Deedwania PC, et al.

ACC/AHA Guidelines for Ambulatory Electrocar- diography. A report of the American College of Car- diology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography).

Developed in collaboration with the North Ameri- can Society for Pacing and Electrophysiology. J Am Coll Cardiol 1999;34:912–948.

3. Dilawar M, Bradley SM, Saul JP, et al. Sinus node dysfunction after intraatrial lateral tunnel and ex- tracardiac conduit Fontan procedures. Pediatr Car- diol 2003; 24(3):284–288.

4. Garrigue S, Bordier P, Jais P, et al. Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med 2002;346:404–412.

5. Gelatt M, Hamilton RM, McCrindle BW, et al. Ar- rhythmia and mortality after the Mustard proce- dure: A 30-year single-center experience. J Am Coll Cardiol 1997;29:194–201.

6. Gregoratos G, Abrams J, Epstein AE, et al.

ACC/AHA/NASPE 2002 guideline update for im- plantation of cardiac pacemakers and antiarrhyth- mia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Cardiovasc Elec- trophysiol 2002;13:1183–1199.

7. Helbing WA, Hansen B, Ottenkamp J, et al. Long- term results of atrial correction for transposition of the great arteries. Comparison of Mustard and Senning operations. J Thorac Cardiovasc Surg 1994;108:363–372.

8. Janousek J, Paul T, Luhmer I, et al. Atrial baffle procedures for complete transposition of the great arteries: natural course of sinus node dysfunction and risk factors for dysrhythmias and sudden death.

Z Kardiol 1994;83:933–938.

9. Kardelen F, Celiker A, Ozer S, et al. Sinus node dysfunction in children and adolescents:

treatment by implantation of a permanent pace- maker in 26 patients. Turk J Pediatr 2002;44:312–

316.

10. Kavey RE, Gaum WE, Byrum CJ, et al. Loss of sinus rhythm after total cavopulmonary connection.

Circulation 1995;92:II304–308.

11. Meijboom F, Szatmari A, Deckers JW, et al. Long- term follow-up (10 to 17 years) after Mustard repair for transposition of the great arteries. J Thorac Car- diovasc Surg 1996;111:1158–1168.

12. Menon A, Silverman ED, Gow RM, Hamilton RM. Chronotropic competence of the sinus node in congenital complete heart block. Am J Cardiol 1998;82:1119–1121, A9.

13. Oberhoffer R, von Bernuth G, Lang D, et al. Sinus node dysfunction in children without heart defect.

Z Kardiol 1994;83:502–506.

14. Ozer S, Schaffer M. Sinus node reentrant tachy- cardia in a neonate. Pacing Clin Electrophysiol 2001;24:1038–1040.

15. Paul T, Ziemer G, Luhmer L, et al. Early and late

atrial dysrhythmias after modified Fontan opera-

tion. Pediatr Med Chir 1998;20:9–11.

Riferimenti

Documenti correlati

In this current review several included studies [23, 26, 29, 30] performed sinus augmentation procedures with simultaneous implant placement in a residual ridge height

Invasive contrast studies have largely been replaced by magnetic resonance imaging (MRI), which visualizes in three dimensions the extra spinal tract path, inclusion tumours and

1 Department of Anesthesiology and Intensive Care, “Carlo Poma” Hospital, ASST Mantova, Via Lago Paiolo, 10, 46100 Mantova, Italy. 2

Caspase-3 in Human Melanoma Cells To verify if the anti-proliferative effect of ADA was related to its ability to induce apoptosis of cancer cells, the cytofluorimetric assay,

gli altri, cfr. DE BÚRCA, Institutional Development of the Eu: a Constitutional Analysis, in P.. In tale assetto la nuova governance economica europea rimarca per la

Stante la modificazioni apportate al Codice della Strada in Francia ed altri Paesi europei non è purtroppo infrequente registrare il transito di veicoli di categoria

After discussing the relevance of big data in relation to urban mobility policy (section 2), the paper examines the available big data and their possible uses in each step of the

Zebrafish gnb5 knockouts recapitulated the phenotypic spectrum of affected individuals, including cardiac, neurolog- ical, and ophthalmological abnormalities, supporting a direct